Yuheng Pharmaceutical (002437.SZ): Pusen Puli intends to transfer 20.64% equity of Yuheng Biotechnology. The proceeds will be used to repay Pusen Puli's debt to the company.

Zhongtong financial app news, Yuheng pharmaceutical (002437.SZ) announced that the company plans to solve the debt dispute between the company and Qingdao Pushengupre Enterprise Management Center (Limited Partnership) (hereinafter referred to as "Pushengupre") regarding the equity transfer payment of Guangzhou Yuheng Bioscience Co., Ltd. (hereinafter referred to as "Yuheng Bioscience") by signing the "Agreement of Guangzhou Yuheng Biotechnology Co., Ltd.", including the specific background, content, impact on the company, and risks.